Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,152Revenue $M159Net Margin (%)-6.6Z-Score2.7
Enterprise Value $M1,275EPS $-0.0Operating Margin %-5.3F-Score2
P/E(ttm))0Cash Flow Per Share $0.4Pre-tax Margin (%)-5.6Higher ROA y-yN
Price/Book6.310-y EBITDA Growth Rate %0Quick Ratio4.5Cash flow > EarningsY
Price/Sales6.95-y EBITDA Growth Rate %0Current Ratio5.3Lower Leverage y-yN
Price/Cash Flow35.6y-y EBITDA Growth Rate %-85.7ROA % (ttm)-4.1Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-5.9Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M41.6ROI % (ttm)-0.1Gross Margin Increase y-yY

Gurus Latest Trades with SPNC

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
Current Price Change from Average Comment Current Shares
SPNCRon Baron 2014-06-30 Add$20.78 - $29.79
$ 27.5319%Add 63.55%60,480
SPNCRon Baron 2014-03-31 Add$24.13 - $31.56
$ 27.531%Add 243.04%36,980
SPNCRon Baron 2013-12-31 Buy $17.2 - $25.43
$ 27.5328%New holding, 10780 sh.10,780
SPNCGeorge Soros 2011-09-30 Sold Out -0.0012%$5.6 - $7.62
$ 27.53323%Sold Out0
SPNCGeorge Soros 2011-06-30 Buy $4.68 - $6.21
$ 27.53392%New holding, 13300 sh.13,300
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

SPNC is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
SPNC Ron Baron 2014-06-3060,4800.150.01+63.55%
Premium Most recent portfolio changes are included for Premium Members only!

SPNC: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
RUGGIO JOSEPH MDirector 2014-09-15Sell10,000$28.19-0.64view
CHILDS GUY ACFO 2014-09-04Sell5,000$28.95-3.25view
Bridges Kimberly McIntoshSr VP, Sales & Mktg, VI 2014-09-03Sell10,382$29.38-4.66view
Ford-Serbu DonnaSr. VP Sales and Mktg, LM 2014-08-29Sell3,000$28.26-0.88view
CHILDS GUY ACFO 2014-08-07Sell5,000$26.635.18view
CHILDS GUY ACFO 2014-07-03Sell5,000$23.5219.09view
CHILDS GUY ACFO 2014-06-05Sell5,000$2227.32view
Bowe Wade AVice President R&D 2014-05-01Sell10,845$21.1832.25view
CHILDS GUY ACFO 2014-05-01Sell5,000$21.1932.18view
CHILDS GUY ACFO 2014-04-03Sell5,000$29.21-4.11view

Press Releases about SPNC :

    Quarterly/Annual Reports about SPNC:

    News about SPNC:

    Articles On GuruFocus.com
    Baron Funds Comments on Spectranetics Corporation Feb 26 2014 
    Spectranetics Corp. Reports Operating Results (10-Q) Nov 08 2010 
    Spectranetics Corp. Reports Operating Results (10-Q) Nov 06 2009 
    Spectranetics Corp. Reports Operating Results (10-Q) Aug 10 2009 
    Spectranetics Corp. Reports Operating Results (10-Q) May 11 2009 
    Spectranetics to Hold 2008 Fourth Quarter Financial Results Conference Call on February 19 Feb 12 2009 
    Spectranetics Cross-Pilot Product Receives FDA Clearance Dec 15 2008 
    Weekly CEO Buys Highlight: Spectranetics Corp., Noven Pharmaceuticals Inc., Dolan Media Company, Mod Sep 09 2008 

    More From Other Websites
    Nasdaq stocks posting largest percentage decreases Sep 19 2014
    Insider Trading Alert - HNT, SPNC And MEAS Traded By Insiders Sep 18 2014
    EXCITE ISR Proves Superiority in Safety, Efficacy of Laser Atherectomy With PTA vs. PTA Alone; Data... Sep 16 2014
    SPECTRANETICS CORP Financials Sep 12 2014
    Spectranetics' EXCITE ISR Data to Be Presented at Transcatheter Cardiovascular Therapeutics (TCT)... Sep 10 2014
    Spectranetics to Participate in Upcoming Investor Conferences Aug 20 2014
    SPECTRANETICS CORP Files SEC form 10-Q, Quarterly Report Aug 11 2014
    Spectranetics to Present at the Canaccord Genuity 34th Annual Growth Conference Jul 30 2014
    Spectranetics (SPNC) Highlighted As Today's Perilous Reversal Stock Jul 25 2014
    Spectranetics (SPNC) in Focus: Stock Rises 6.1% Jul 25 2014
    SPECTRANETICS CORP Files SEC form 8-K, Results of Operations and Financial Condition, Other Events,... Jul 24 2014
    Spectranetics Achieves Second Quarter 2014 Revenue of $43.6 Million Jul 24 2014
    Spectranetics remains a top small cap pick, says Canaccord Jul 24 2014
    Q2 2014 Spectranetics Earnings Release - After Market Close Jul 24 2014
    Spectranetics receives FDA clearance of peripheral laser atherectomy devices Jul 23 2014
    Spectranetics Announces FDA Clearance of Peripheral Laser Atherectomy Devices for In-Stent... Jul 23 2014
    Spectranetics to meet or beat, remains a top small-cap idea, says Canaccord Jul 21 2014
    AngioScore Launches New 200 mm Length AngioSculpt(R) Scoring Balloon Catheters Jul 09 2014
    Spectranetics to Hold 2014 Second Quarter Financial Results Conference Call on July 24 Jul 07 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial